Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2024

Open Access 01-12-2024 | Cholangiocarcinoma | Research

Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China

Authors: Guan Huang, Haofeng Zhang, Zhenwei Yang, Qingshan Li, Hao Yuan, Pengyu Chen, Chenxi Xie, Bo Meng, Xianzhou Zhang, Kunlun Chen, Haibo Yu

Published in: World Journal of Surgical Oncology | Issue 1/2024

Login to get access

Abstract

Background

Intrahepatic cholangiocarcinoma (ICC) is a highly malignant tumor with a poor prognosis. This study aimed to investigate whether Hemoglobin, Albumin, Lymphocytes, and Platelets (HALP) score and Tumor Burden Score (TBS) serves as independent influencing factors following radical resection in patients with ICC. Furthermore, we sought to evaluate the predictive capacity of the combined HALP and TBS grade, referred to as HTS grade, and to develop a prognostic prediction model.

Methods

Clinical data for ICC patients who underwent radical resection were retrospectively analyzed. Univariate and multivariate Cox regression analyses were first used to find influencing factors of prognosis for ICC. Receiver operating characteristic (ROC) curves were then used to find the optimal cut-off values for HALP score and TBS and to compare the predictive ability of HALP, TBS, and HTS grade using the area under these curves (AUC). Nomogram prediction models were constructed and validated based on the results of the multivariate analysis.

Results

Among 423 patients, 234 (55.3%) were male and 202 (47.8) were aged ≥ 60 years. The cut-off value of HALP was found to be 37.1 and for TBS to be 6.3. Our univariate results showed that HALP, TBS, and HTS grade were prognostic factors of ICC patients (all P < 0.05), and ROC results showed that HTS had the best predictive value. The Kaplan–Meier curve showed that the prognosis of ICC patients was worse with increasing HTS grade. Additionally, multivariate regression analysis showed that HTS grade, carbohydrate antigen 19–9 (CA19-9), tumor differentiation, and vascular invasion were independent influencing factors for Overall survival (OS) and that HTS grade, CA19-9, CEA, vascular invasion and lymph node invasion were independent influencing factors for recurrence-free survival (RFS) (all P < 0.05). In the first, second, and third years of the training group, the AUCs for OS were 0.867, 0.902, and 0.881, and the AUCs for RFS were 0.849, 0.841, and 0.899, respectively. In the first, second, and third years of the validation group, the AUCs for OS were 0.727, 0.771, and 0.763, and the AUCs for RFS were 0.733, 0.746, and 0.801, respectively. Through the examination of calibration curves and using decision curve analysis (DCA), nomograms based on HTS grade showed excellent predictive performance.

Conclusions

Our nomograms based on HTS grade had excellent predictive effects and may thus be able to help clinicians provide individualized clinical decision for ICC patients.
Literature
1.
go back to reference Florio AA, Ferlay J, Znaor A, Ruggieri D, Alvarez CS, Laversanne M, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666–78.CrossRefPubMed Florio AA, Ferlay J, Znaor A, Ruggieri D, Alvarez CS, Laversanne M, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666–78.CrossRefPubMed
3.
go back to reference Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B, et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):7–18.CrossRefPubMed Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B, et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):7–18.CrossRefPubMed
4.
go back to reference Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19–31.CrossRefPubMed Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19–31.CrossRefPubMed
5.
go back to reference Kupietzky A, Ariche A. Surgical aspects of intrahepatic cholangiocarcinoma. Cancers (Basel). 2022;14:6265.CrossRefPubMed Kupietzky A, Ariche A. Surgical aspects of intrahepatic cholangiocarcinoma. Cancers (Basel). 2022;14:6265.CrossRefPubMed
6.
go back to reference Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol. 2016;23(1):235–43.CrossRefPubMed Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol. 2016;23(1):235–43.CrossRefPubMed
7.
go back to reference Jutric Z, Johnston WC, Hoen HM, Newell PH, Cassera MA, Hammill CW, et al. Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database. HPB (Oxford). 2016;18(1):79–87.CrossRefPubMed Jutric Z, Johnston WC, Hoen HM, Newell PH, Cassera MA, Hammill CW, et al. Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database. HPB (Oxford). 2016;18(1):79–87.CrossRefPubMed
8.
go back to reference Zhang XF, Beal EW, Bagante F, Chakedis J, Weiss M, Popescu I, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018;105(7):848–56.CrossRefPubMed Zhang XF, Beal EW, Bagante F, Chakedis J, Weiss M, Popescu I, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018;105(7):848–56.CrossRefPubMed
9.
go back to reference Schobert IT, Savic LJ, Chapiro J, Bousabarah K, Chen E, Laage-Gaupp F, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Eur Radiol. 2020;30(10):5663–73.CrossRefPubMedPubMedCentral Schobert IT, Savic LJ, Chapiro J, Bousabarah K, Chen E, Laage-Gaupp F, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Eur Radiol. 2020;30(10):5663–73.CrossRefPubMedPubMedCentral
10.
go back to reference Kaneko S, Kurosaki M, Tsuchiya K, Yasui Y, Inada K, Kirino S, et al. Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade. Hepatol Res. 2021;51(8):902–8.CrossRefPubMed Kaneko S, Kurosaki M, Tsuchiya K, Yasui Y, Inada K, Kirino S, et al. Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade. Hepatol Res. 2021;51(8):902–8.CrossRefPubMed
11.
go back to reference Toshida K, Itoh S, Nakayama Y, Tsutsui Y, Kosai-Fujimoto Y, Tomino T, et al. Preoperative HALP score is a prognostic factor for intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection: association with sarcopenia and immune microenvironment. Int J Clin Oncol. 2023;28:1082–91.CrossRefPubMed Toshida K, Itoh S, Nakayama Y, Tsutsui Y, Kosai-Fujimoto Y, Tomino T, et al. Preoperative HALP score is a prognostic factor for intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection: association with sarcopenia and immune microenvironment. Int J Clin Oncol. 2023;28:1082–91.CrossRefPubMed
12.
go back to reference Zhang D, Zeng H, Pan Y, Zhao Y, Wang X, Chen J, et al. Liver tumor markers, HALP score, and NLR: simple, cost-effective, easily accessible indexes for predicting prognosis in ICC patients after surgery. J Pers Med. 2022;12:2041.CrossRefPubMedPubMedCentral Zhang D, Zeng H, Pan Y, Zhao Y, Wang X, Chen J, et al. Liver tumor markers, HALP score, and NLR: simple, cost-effective, easily accessible indexes for predicting prognosis in ICC patients after surgery. J Pers Med. 2022;12:2041.CrossRefPubMedPubMedCentral
13.
go back to reference Sasaki K, Morioka D, Conci S, Margonis GA, Sawada Y, Ruzzenente A, et al. The tumor burden score: a new, “Metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267(1):132–41.CrossRefPubMed Sasaki K, Morioka D, Conci S, Margonis GA, Sawada Y, Ruzzenente A, et al. The tumor burden score: a new, “Metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267(1):132–41.CrossRefPubMed
14.
go back to reference Moris D, Shaw BI, McElroy L, Barbas AS. Using hepatocellular carcinoma tumor burden score to stratify prognosis after liver transplantation. Cancers (Basel). 2020;12:3372.CrossRefPubMed Moris D, Shaw BI, McElroy L, Barbas AS. Using hepatocellular carcinoma tumor burden score to stratify prognosis after liver transplantation. Cancers (Basel). 2020;12:3372.CrossRefPubMed
15.
go back to reference Li H, Liu R, Qiu H, Huang Y, Liu W, Li J, et al. Tumor burden score stratifies prognosis of patients with intrahepatic cholangiocarcinoma after hepatic resection: a retrospective. Multi-Institutional Study Front Oncol. 2022;12: 829407.PubMed Li H, Liu R, Qiu H, Huang Y, Liu W, Li J, et al. Tumor burden score stratifies prognosis of patients with intrahepatic cholangiocarcinoma after hepatic resection: a retrospective. Multi-Institutional Study Front Oncol. 2022;12: 829407.PubMed
16.
go back to reference Zhang W, Ji L, Wang X, Zhu S, Luo J, Zhang Y, et al. Nomogram predicts risk and prognostic factors for bone metastasis of pancreatic cancer: a population-based analysis. Front Endocrinol. 2021;12: 752176.CrossRef Zhang W, Ji L, Wang X, Zhu S, Luo J, Zhang Y, et al. Nomogram predicts risk and prognostic factors for bone metastasis of pancreatic cancer: a population-based analysis. Front Endocrinol. 2021;12: 752176.CrossRef
18.
go back to reference Vickers AJ, Holland F. Decision curve analysis to evaluate the clinical benefit of prediction models. The Spine J. 2021;21(10):1643–8.CrossRefPubMed Vickers AJ, Holland F. Decision curve analysis to evaluate the clinical benefit of prediction models. The Spine J. 2021;21(10):1643–8.CrossRefPubMed
19.
go back to reference Krenzien F, Nevermann N, Krombholz A, Benzing C, Haber P, Fehrenbach U, et al. Treatment of intrahepatic cholangiocarcinoma-a multidisciplinary approach. Cancers (Basel). 2022;14:362.CrossRefPubMed Krenzien F, Nevermann N, Krombholz A, Benzing C, Haber P, Fehrenbach U, et al. Treatment of intrahepatic cholangiocarcinoma-a multidisciplinary approach. Cancers (Basel). 2022;14:362.CrossRefPubMed
21.
go back to reference Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):353–63.CrossRefPubMed Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):353–63.CrossRefPubMed
22.
go back to reference Sellers CM, Uhlig J, Ludwig JM, Stein SM, Kim HS. Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease. Cancer Med. 2019;8(13):5916–29.CrossRefPubMedPubMedCentral Sellers CM, Uhlig J, Ludwig JM, Stein SM, Kim HS. Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease. Cancer Med. 2019;8(13):5916–29.CrossRefPubMedPubMedCentral
23.
go back to reference Li H, Wang JJ, Zhang M, Ren B, Li JX, Xu L, et al. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection. World J Gastrointest Oncol. 2020;12(4):467–82.CrossRefPubMedPubMedCentral Li H, Wang JJ, Zhang M, Ren B, Li JX, Xu L, et al. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection. World J Gastrointest Oncol. 2020;12(4):467–82.CrossRefPubMedPubMedCentral
24.
go back to reference Li Q, Chen C, Zhang J, Wu H, Qiu Y, Song T, et al. Prediction efficacy of prognostic nutritional index and albumin-bilirubin grade in patients with intrahepatic cholangiocarcinoma after radical resection: a multi-institutional analysis of 535 patients. Front Oncol. 2021;11: 769696.CrossRefPubMedPubMedCentral Li Q, Chen C, Zhang J, Wu H, Qiu Y, Song T, et al. Prediction efficacy of prognostic nutritional index and albumin-bilirubin grade in patients with intrahepatic cholangiocarcinoma after radical resection: a multi-institutional analysis of 535 patients. Front Oncol. 2021;11: 769696.CrossRefPubMedPubMedCentral
25.
go back to reference Belcher DA, Ju JA, Baek JH, Yalamanoglu A, Buehler PW, Gilkes DM, et al. The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study. PLoS ONE. 2018;13(2): e0191275.CrossRefPubMedPubMedCentral Belcher DA, Ju JA, Baek JH, Yalamanoglu A, Buehler PW, Gilkes DM, et al. The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study. PLoS ONE. 2018;13(2): e0191275.CrossRefPubMedPubMedCentral
26.
go back to reference Nazha B, Moussaly E, Zaarour M, Weerasinghe C, Azab B. Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate? World J Gastrointest Surg. 2015;7(12):370–7.CrossRefPubMedPubMedCentral Nazha B, Moussaly E, Zaarour M, Weerasinghe C, Azab B. Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate? World J Gastrointest Surg. 2015;7(12):370–7.CrossRefPubMedPubMedCentral
27.
go back to reference Sasaki K, Margonis GA, Andreatos N, Bagante F, Weiss M, Barbon C, et al. Preoperative risk score and prediction of long-term outcomes after hepatectomy for intrahepatic cholangiocarcinoma. J Am Coll Surg. 2018;226(4):393–403.CrossRefPubMed Sasaki K, Margonis GA, Andreatos N, Bagante F, Weiss M, Barbon C, et al. Preoperative risk score and prediction of long-term outcomes after hepatectomy for intrahepatic cholangiocarcinoma. J Am Coll Surg. 2018;226(4):393–403.CrossRefPubMed
29.
go back to reference Sun L, Guan A, Jin Y, Liu M, Xiao Y, Xu H, et al. Comparison of prognostic value of red cell-related parameters of biliary tract cancer after surgical resection and integration of a prognostic nomogram: a retrospective study. Adv Ther. 2021;38(2):1227–44.CrossRefPubMed Sun L, Guan A, Jin Y, Liu M, Xiao Y, Xu H, et al. Comparison of prognostic value of red cell-related parameters of biliary tract cancer after surgical resection and integration of a prognostic nomogram: a retrospective study. Adv Ther. 2021;38(2):1227–44.CrossRefPubMed
30.
go back to reference Cheng Z, Lei Z, Si A, Yang P, Luo T, Guo G, et al. Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2019;21(12):1656–66. Cheng Z, Lei Z, Si A, Yang P, Luo T, Guo G, et al. Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2019;21(12):1656–66.
31.
go back to reference Yonekawa Y, Uehara K, Mizuno T, Aiba T, Ogura A, Mukai T, et al. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score. Int J Clin Oncol. 2021;26(1):126–34.CrossRefPubMed Yonekawa Y, Uehara K, Mizuno T, Aiba T, Ogura A, Mukai T, et al. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score. Int J Clin Oncol. 2021;26(1):126–34.CrossRefPubMed
32.
go back to reference Wang J, Chen Z, Wang L, Feng S, Qiu Q, Chen D, et al. A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection. Sci Rep. 2022;12(1):8670.CrossRefPubMedPubMedCentral Wang J, Chen Z, Wang L, Feng S, Qiu Q, Chen D, et al. A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection. Sci Rep. 2022;12(1):8670.CrossRefPubMedPubMedCentral
33.
go back to reference Moazzam Z, Alaimo L, Endo Y, Lima HA, Ruzzenente A, Guglielmi A, et al. Combined tumor burden score and carbohydrate antigen 19–9 grading system to predict outcomes among patients with intrahepatic cholangiocarcinoma. J Am Coll Surg. 2023;236(4):804–13.CrossRefPubMed Moazzam Z, Alaimo L, Endo Y, Lima HA, Ruzzenente A, Guglielmi A, et al. Combined tumor burden score and carbohydrate antigen 19–9 grading system to predict outcomes among patients with intrahepatic cholangiocarcinoma. J Am Coll Surg. 2023;236(4):804–13.CrossRefPubMed
34.
go back to reference Huang X, Luo Z, Liang W, Xie G, Lang X, Gou J, et al. Survival nomogram for young breast cancer patients based on the SEER database and an external validation cohort. Ann Surg Oncol. 2022;29(9):5772–81.CrossRefPubMedPubMedCentral Huang X, Luo Z, Liang W, Xie G, Lang X, Gou J, et al. Survival nomogram for young breast cancer patients based on the SEER database and an external validation cohort. Ann Surg Oncol. 2022;29(9):5772–81.CrossRefPubMedPubMedCentral
35.
go back to reference Fan Y, Wang Y, He L, Imani S, Wen Q. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival. ESMO Open. 2021;6(4): 100232.CrossRefPubMedPubMedCentral Fan Y, Wang Y, He L, Imani S, Wen Q. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival. ESMO Open. 2021;6(4): 100232.CrossRefPubMedPubMedCentral
36.
go back to reference Chen Y, Liu H, Zhang J, Wu Y, Zhou W, Cheng Z, et al. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China. BMC Cancer. 2021;21(1):1299.CrossRefPubMedPubMedCentral Chen Y, Liu H, Zhang J, Wu Y, Zhou W, Cheng Z, et al. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China. BMC Cancer. 2021;21(1):1299.CrossRefPubMedPubMedCentral
37.
go back to reference Shen H, Zhang S, Xia Y, Chen C, Huo L, Gan L, et al. A nomogram in predicting risks of intrahepatic cholangiocarcinoma after partial hepatectomy for hepatolithiasis. J Gastrointest Surg. 2021;25(9):2258–67.CrossRefPubMed Shen H, Zhang S, Xia Y, Chen C, Huo L, Gan L, et al. A nomogram in predicting risks of intrahepatic cholangiocarcinoma after partial hepatectomy for hepatolithiasis. J Gastrointest Surg. 2021;25(9):2258–67.CrossRefPubMed
Metadata
Title
Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China
Authors
Guan Huang
Haofeng Zhang
Zhenwei Yang
Qingshan Li
Hao Yuan
Pengyu Chen
Chenxi Xie
Bo Meng
Xianzhou Zhang
Kunlun Chen
Haibo Yu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2024
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-023-03281-6

Other articles of this Issue 1/2024

World Journal of Surgical Oncology 1/2024 Go to the issue